Skip to content

Ginkgo Bioworks DNA Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-192%+54.6pp-246.5%+97.2pp-343.8%+119pp-462.4%+120pp
Net margin-195.4%+45.5pp-240.9%+114pp-355.1%+85.6pp-440.6%+142pp
Returns
Return on equity-51.1%+9.3pp-60.3%+2.7pp-63%+66.8pp-129.9%+56.2pp
Return on invested capital-46.8%+73.9pp-120.7%+28.3pp-149%+335pp-484.3%+1,406pp
Efficiency
Asset turnover0.1×0.0×0.1×0.0×0.1×-0.1×0.2×0.0×
Liquidity
Current ratio4.9×-0.7×5.6×-0.5×6.1×-2.3×8.4×-4.4×
Leverage
Debt-to-equity0.9×+0.2×0.7×+0.4×0.2×0.0×0.3×+0.1×
Per Share
Book value per share$9.17-33.5%$13.80-38.9%$22.57-45.4%$41.34+3,636%
Valuation
Market capitalization$625.16M+24.6%$564.44M-84.2%$3.58B+9.2%$3.28B-76.4%
Price / sales4.4×+2.2×2.5×-11.8×14.2×+7.4×6.9×-37.4×
Price / book1.4×+0.6×0.8×-2.5×3.3×+1.4×1.9×-7.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Ginkgo Bioworks's ratios come from?
Every ratio is computed from Ginkgo Bioworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.